These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 24331821
1. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region. Jumaan AO, Ghanem S, Taher J, Braikat M, Al Awaidy S, Dbaibo GS. Vaccine; 2013 Dec 30; 31 Suppl 6():G58-64. PubMed ID: 24331821 [Abstract] [Full Text] [Related]
2. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Vaccine; 2013 Dec 30; 31 Suppl 6():G65-77. PubMed ID: 24331822 [Abstract] [Full Text] [Related]
3. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA. Vaccine; 2013 Dec 29; 31 Suppl 5():F47-52. PubMed ID: 24331747 [Abstract] [Full Text] [Related]
4. Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region. Vaccarella S, Bruni L, Seoud M. Vaccine; 2013 Dec 30; 31 Suppl 6():G32-44. PubMed ID: 24331818 [Abstract] [Full Text] [Related]
8. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Vaccine; 2013 Dec 29; 31 Suppl 5():F60-72. PubMed ID: 24331749 [Abstract] [Full Text] [Related]
9. Barriers to human papillomavirus vaccine acceptability in Israel. Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J. Vaccine; 2013 Nov 22; 31 Suppl 8():I53-7. PubMed ID: 24229720 [Abstract] [Full Text] [Related]
12. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA. Vaccine; 2013 Dec 29; 31 Suppl 5():F53-9. PubMed ID: 24331748 [Abstract] [Full Text] [Related]
13. Cost-utility analysis of interventions to reduce the burden of cervical cancer in Israel. Ginsberg GM. Vaccine; 2013 Nov 22; 31 Suppl 8():I46-52. PubMed ID: 24229719 [Abstract] [Full Text] [Related]
14. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. Seoud M. J Low Genit Tract Dis; 2012 Apr 22; 16(2):106-20. PubMed ID: 22371041 [Abstract] [Full Text] [Related]